Recent years, increasing evidence showed that abnormal expression of SETDB1 is closely related to tumorigenesis, including melanoma, lung cancer, breast cancer, and liver cancer23–26, suggesting that SETDB1 is involved in the pathogenesis of a variety of human cancers. Here, SETDB1 is linked to lung carcinoma.